Pure erythroid leukemia

Jason C. Chen; Winston Y. Lee; Jordan K. Schaefer; Dale L. Bixby

doi:10.1002/ccr3.3056

Clinical Case Reports (Nov 2020)

Pure erythroid leukemia

Jason C. Chen,
Winston Y. Lee,
Jordan K. Schaefer,
Dale L. Bixby

Affiliations

Jason C. Chen: Division of Hematology and Medical Oncology Department of Internal Medicine University of Michigan Ann Arbor Michigan
Winston Y. Lee: Department of Pathology University of Michigan Ann Arbor Michigan
Jordan K. Schaefer: Division of Hematology and Medical Oncology Department of Internal Medicine University of Michigan Ann Arbor Michigan
Dale L. Bixby: Division of Hematology and Medical Oncology Department of Internal Medicine University of Michigan Ann Arbor Michigan

DOI: https://doi.org/10.1002/ccr3.3056
Journal volume & issue: Vol. 8, no. 11
pp. 2286 – 2288

Abstract

Read online

Abstract The diagnosis of pure erythroid leukemia (PEL) can be challenging. Prompt identification of CD45+, CD34‐, CD71+, CD117+, and E‐cadherin+ erythroblasts is important. The differential diagnosis is broad and includes megaloblastic anemia.

Published in Clinical Case Reports

ISSN: 2050-0904 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2050-0904

About the journal

Abstract

Keywords